Buy or sell Atomwise stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Atomwise Stock

Atomwise develops artificial intelligence systems using powerful deep learning algorithms and supercomputers for drug discovery.

About Atomwise Stock

The Atomwise Advantage Using computers to discover medicines is a great idea, but execution is everything. With lives and budgets on the line, accuracy matters. Previous attempts haven't always met expectations. The techniques of the day were limited by the knowledge and computers available. Today, things are different. They have invented cutting-edge machine learning algorithms that are built specifically for the world's most powerful computers. They use one of the world's top supercomputers to analyze databases 1000 times larger than those used in the past. This lets us deliver what many others can't: precise and reliable medicinal predictions.

Funding History

January 2013$225K
December 2014$120K
March 2015$225K
June 2015$6.0M

Management

CEO

Abraham Heifets

CTO

Dr. Izhar Wallach

COO

Alexander Levy

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Atomwise or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 130K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo